A phase II study of active immunotherapy with PANVACTM or autologous, cultured dendritic cells infected with PANVACTM after complete resection of hepatic metastases of colorectal carcinoma

Emil Lou, John Marshall, Mebea Aklilu, David Cole, David Chang, Michael Morse

Research output: Contribution to journalArticlepeer-review

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)368-371
Number of pages4
JournalClinical Colorectal Cancer
Issue number5
StatePublished - Jan 2006

Bibliographical note

Funding Information:
This clinical trial is supported by the National Institutes of Health grant P01-CA078673-06 Project 1.


  • Granulocyte-monocyte colony-stimulating factor
  • Performance status
  • Pox vectors

Cite this